Cargando…

Metformin use and improved response to therapy in rectal cancer

Locally advanced rectal cancer is commonly treated with chemoradiation prior to total mesorectal excision (TME). Studies suggest that metformin may be an effective chemopreventive agent in this disease as well as a possible adjunct to current therapy. In this study, we examined the effect of metform...

Descripción completa

Detalles Bibliográficos
Autores principales:	Skinner, Heath D., Crane, Christopher H., Garrett, Christopher R., Eng, Cathy, Chang, George J., Skibber, John M., Rodriguez-Bigas, Miguel A., Kelly, Patrick, Sandulache, Vlad C., Delclos, Marc E., Krishnan, Sunil, Das, Prajnan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2013
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797563/ https://www.ncbi.nlm.nih.gov/pubmed/24133632 http://dx.doi.org/10.1002/cam4.54

Ejemplares similares

Treatment of primary rectal adenocarcinoma after prior pelvic radiation: The role of hyperfractionated accelerated reirradiation
por: Jensen, Garrett, et al.
Publicado: (2018)

A phase II randomized double blinded trial evaluating the efficacy of curcumin with pre-operative chemoradiation for rectal cancer
por: Gunther, Jillian R., et al.
Publicado: (2022)

Intensity modulated radiation therapy (IMRT): differences in target volumes and improvement in clinically relevant doses to small bowel in rectal carcinoma
por: Mok, Henry, et al.
Publicado: (2011)

Preoperative radiation dose escalation for rectal cancer using a concomitant boost strategy improves tumor downstaging without increasing toxicity: A matched-pair analysis
por: Gunther, Jillian R., et al.
Publicado: (2017)

Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution
por: Holliday, Emma B, et al.
Publicado: (2022)

Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects
por: Veeramachaneni, Ratna, et al.
Publicado: (2021)

Reirradiation to the abdomen for gastrointestinal malignancies
por: Haque, Waqar, et al.
Publicado: (2009)

Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centers
por: Reyngold, Marsha, et al.
Publicado: (2017)

Transoral Laser Surgery for Laryngeal Cancer
por: Sandulache, Vlad C., et al.
Publicado: (2014)

Concurrent capecitabine and upper abdominal radiation therapy is well tolerated
por: Das, Prajnan, et al.
Publicado: (2006)

IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer
por: Moningi, Shalini, et al.
Publicado: (2019)

The role of systemic chemotherapy and multidisciplinary management in improving the overall survival of patients with metastatic squamous cell carcinoma of the anal canal
por: Eng, Cathy, et al.
Publicado: (2014)

Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?
por: Dhawan, Annika, et al.
Publicado: (2022)

CEA as a blood-based biomarker in anal cancer
por: Hester, Robert, et al.
Publicado: (2021)

Phase I Trial of Consolidative Radiotherapy with Concurrent Bevacizumab, Erlotinib and Capecitabine for Unresectable Pancreatic Cancer
por: Chadha, Awalpreet S., et al.
Publicado: (2016)

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
por: Kim, Jin K, et al.
Publicado: (2022)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

High expression of oxidative phosphorylation genes predicts improved survival in squamous cell carcinomas of the head and neck and lung
por: Frederick, Mitchell, et al.
Publicado: (2020)

ACR Appropriateness Criteria(® Resectable Rectal Cancer)
por: Jones, William E, et al.
Publicado: (2012)

A comparison between Lynch syndrome and sporadic colorectal cancer survivors’ satisfaction with their healthcare providers
por: Burton‐Chase, Allison M., et al.
Publicado: (2017)

Incidence and survival for oropharynx and non‐oropharynx head and neck cancers among veterans living with HIV
por: Mazul, Angela L., et al.
Publicado: (2020)

Abnormal bowel movement frequency increases the risk of rectal cancer: evidence from cohort studies with one million people
por: Shen, Lin, et al.
Publicado: (2020)

Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation
por: Groenendijk, Floris H, et al.
Publicado: (2015)

Prognostic value of the post-operative red blood cell distribution width in patients with rectal cancer with neoadjuvant chemoradiation followed by surgery
por: Ren, Yingkun, et al.
Publicado: (2020)

The Current State of Targeted Agents in Rectal Cancer
por: Kim, Dae Dong, et al.
Publicado: (2012)

Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving Treatment
por: Maas, Monique, et al.
Publicado: (2015)

Metformin induces degradation of mTOR protein in breast cancer cells
por: Alalem, Mohamed, et al.
Publicado: (2016)

Metformin is a metabolic modulator and radiosensitiser in rectal cancer
por: Buckley, Croí E., et al.
Publicado: (2023)

Jupiter microtubule‐associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers
por: Bateman, Nicholas W., et al.
Publicado: (2019)

Treatment of Inguinal Lymph Node Metastases in Patients with Rectal Adenocarcinoma
por: Hagemans, J. A. W., et al.
Publicado: (2019)

Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible
por: Dijkstra, Esmée A., et al.
Publicado: (2021)

Evaluation of Hyperpolarized [1-(13)C]-Pyruvate by Magnetic Resonance to Detect Ionizing Radiation Effects in Real Time
por: Sandulache, Vlad C., et al.
Publicado: (2014)

Metformin prevents DMH-induced colorectal cancer in diabetic rats by reversing the warburg effect
por: Jia, Yanglei, et al.
Publicado: (2015)

Antiproliferative and metabolic effects of metformin in a preoperative window clinical trial for endometrial cancer
por: Schuler, Kevin M, et al.
Publicado: (2015)

Survival in colon and rectal cancers in Finland and Sweden through 50 years
por: Hemminki, Kari, et al.
Publicado: (2021)

Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer
por: Solbakken, Arne M., et al.
Publicado: (2023)

Optimal Treatment Strategy in Rectal Cancer Surgery: Should We Be Cowboys or Chickens?
por: Snijders, Heleen S., et al.
Publicado: (2015)

The Role of transanal (Ta) dissection in the management of difficult primary and recurrent rectal cancer
por: Courval, Valérie, et al.
Publicado: (2019)

Digital Rectal Examination in Stockholm3 Biomarker-based Prostate Cancer Screening
por: Andersson, Joel, et al.
Publicado: (2022)

Systematic Review of Patient-Reported Outcome Measures in Locally Recurrent Rectal Cancer
por: McKigney, Niamh, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_grbcr3t34ab2pe3b2smv8oorsp